Author:
van Hoesel A Q,Sato Y,Elashoff D A,Turner R R,Giuliano A E,Shamonki J M,Kuppen P J K,van de Velde C J H,Hoon D S B
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Agathanggelou A, Cooper WN, Latif F (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65 (9): 3497–3508
2. Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, Mamounas EP, Julian TB, Geyer CE Jr, Costantino JP, Land SR, Wolmark N (2012) Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 30 (12): 1268–1273
3. Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC (2009) NCCN task force report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw 7 (Suppl): 6S1–S21,, quiz S22–S23
4. Allred DC, Mohsin SK (2000) Biological features of premalignant disease in the human breast. J Mammary Gland Biol Neoplasia 5 (4): 351–364
5. Bastogne T, Samson A, Vallois P, Wantz-Mezieres S, Pinel S, Bechet D, Barberi-Heyob M (2010) Phenomenological modeling of tumor diameter growth based on a mixed effects model. J Theor Biol 262 (3): 544–552
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献